Every recall we track for Amerisource Health Services LLC — 46 in all — plus the complaints and injury reports the public filed about them.
Amerisource Health recalls Primidone 250mg tablets due to cross contamination with Acemetacin. This may affect patients taking this medication. Contact for details.
Amerisource Health Services recalls Primidone 50mg tablets due to cross contamination with Acemetacin. Affected lots may pose health risks if taken.
Amerisource Health Services recalls 12.5mg Meclizine tablets due to failed specifications. This affects certain lots and requires checking your product details.
Amerisource Health Services recalls 5mg oxycodone tablets with weak blister seals that may cause tablets to fall out. Stop using if you have these specific packaging.
Amerisource Health recalls 1 mg Prazosin capsules due to potential carcinogenic impurity. Affected lots may pose cancer risk; contact for return instructions.
Amerisource Health recalls 2mg Prazosin capsules due to potential carcinogenic impurity. Consumers should check carton NDC 68084-997-01 and lot numbers for affected units.
Amerisource Health recalls 5mg Prazosin capsules with N-nitroso impurity above safety limits. This may increase cancer risk. Stop using and contact for return.
Amerisource Health Services recalls Sucralfate Tablets due to CGMP deviations affecting product quality. Products may not meet identity, strength, quality, or purity standards. Consumers should contact the manufacturer for details.
Amerisource Health Services recalls 400mg carbamazepine extended-release tablets due to failed dissolution specifications. Affected lots may not release medication properly.
Amerisource Health Services recalls chlorpromazine hydrochloride tablets with specific NDC numbers due to a foreign micro-organism in packaging. No microorganisms were found on the tablets themselves.
Amerisource Health recalls chlorpromazine hydrochloride tablets with specific lot numbers due to a microorganism found in packaging. No tablets were contaminated. Consumers should check their lot numbers and contact the manufacturer for details.
Amerisource Health recalls chlorpromazine hydrochloride tablets (50mg) with specific lots due to a microorganism found in packaging. No tablets were contaminated. Consumers should contact the manufacturer for details.
Amerisource Health Services recalls chlorpromazine 200mg tablets due to a microorganism found in packaging material. No tablets were contaminated. Consumers should contact the manufacturer for details.
Amerisource Health Services recalls certain Sucralfate Tablets due to CGMP deviations affecting product quality. Products may not meet identity, strength, or purity standards, posing potential safety risks.
Amerisource Health Services is recalling Indomethacin Extended-Release Capsules (75mg) due to cGMP deviations. This recall affects prescription-only products with specific lot numbers and expiration dates.
Amerisource Health Services recalls Haloperidol Decanoate Injection due to bacterial contamination detected in some units. This injectable medication poses a risk of infection if used.
Amerisource Health Services recalls Haloperidol Decanoate Injection vials due to bacterial contamination detected in some media fill units. This poses a risk of infection if injected.
Amerisource Health Services recalls Haloperidol Decanoate Injection due to bacterial contamination in some units. This injectable medication poses a risk of infection if used.
Amerisource Health Services is recalling Voriconazole 50mg tablets (30 doses per carton) because they were repackaged by a supplier, potentially affecting drug safety.
Amerisource Health Services recalls Clobazam 10mg tablets due to foreign tablets/capsules in packaging. Affected lots: 1018598, expiring 10/31/2025. No remedy specified in recall notice.
Amerisource Health Services recalls glipiZIDE Extended-Release Tablets 2.5mg 30-count due to failed dissolution specifications. This could affect medication effectiveness. Check your carton for lot number 1012910.
Amneal Pharmaceuticals recalls 10mg Clobazam tablets due to foreign tablets in packaging. Affected lots: 1019594, expiring 12/31/2025. Stop using and contact for replacement.
Amerisource Health Services recalls 60mg Duloxetine capsules due to potential N-nitroso impurity above safety limits. This may pose health risks. Consumers should contact the manufacturer for details.
Amerisource Health Services recalls 20mg Duloxetine capsules due to potential N-nitroso impurity exceeding safety limits. Affected lots manufactured in India for BluePoint Laboratories.
Amerisource Health Services recalls Duloxetine 30mg and 1000-count capsules due to potential impurity levels exceeding safety limits. Consumers should contact the manufacturer for details.
Amerisource Health Services recalls Potassium Chloride Extended-Release Capsules due to failed dissolution specifications. This may affect potassium levels in the body. Check product details and contact the manufacturer for remedy.
Amerisource Health recalls buPRODIA 150mg extended-release tablets that dissolve faster than intended. This may affect medication effectiveness. Check your carton for lot number 1017343.
Amerisource Health Services recalls Febuxostat 40mg tablets due to CGMP deviations. These prescription drugs may have manufacturing issues affecting safety. Check your NDC numbers for affected lots.
Amerisource Health recalls Rifampin Capsules USP 150mg due to failed impurities/degradation. Rx-only medication with specific NDC numbers and expiration date. Consumers should contact pharmacy for details.
Amerisource Health Services recalls 100-mg benzonatate capsules due to slightly higher drug concentration than specified. This may cause unintended effects. Check your carton for NDC 68084-214-01 or lot #1014208.
Amerisource Health Services recalls HydrALAZINE Hydrochloride Tablets due to impurities detected at 12 months. This may affect safety if stored too long. Check your carton for NDC 68084-447-01.
Amerisource Health Services recalls Tizanidine 4mg tablets due to failed dissolution specifications. This repackaged product may not dissolve properly as tested, potentially affecting medication effectiveness.
Amerisource Health Services recalls Glimepiride 1mg tablets due to FDA inspection findings. Products with specific NDC numbers and batch dates are affected.
Amerisource Health Services recalls Glimepiride 2mg tablets due to FDA inspection findings. Products with NDC numbers 68001-178-00 and 68001-178-03 may be affected.
Amerisource Health Services recalls Glimepiride 4mg tablets due to FDA inspection finding manufacturing deviations. Affected products include 100-count and 500-count bottles with specific NDC numbers and batch dates.
Amerisource Health Services recalls 180mg verapamil extended-release tablets due to failed dissolution tests. This may affect medication effectiveness. Check NDC 60687-504-01 for affected lots.
Amerisource Health Services recalls 120mg Verapamil Hydrochloride Extended-Release Tablets due to failed dissolution testing. This may affect medication effectiveness. Check NDC 60687-493-01 for affected lots.
Amerisource Health Services recalls Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. Affected lots have expired by 03/31/2023 or 02/28/2023. Discard or contact for replacement.
Amerisource Health is recalling 75mg BuPROPion Hydrochloride tablets (Rx only) because of failed impurities and degradation specifications. The affected lot expires January 2023.
Amerisource Health Services recalls Rifampin Capsules USP 300mg due to failed impurities and degradations. This medication is prescription-only and may pose health risks if used.
Amerisource Health Services recalls Azacit: 100 mg lyophilized powder vials due to subpotent drug risk. Affected patients should contact their doctor for guidance.
